Carma Bylund
Professor | University of Florida
Gainesville, FL, UNITED STATES
Carma Bylund is a behavioral scientist with international expertise in healthcare communication across the cancer continuum and in dementia.
Biography
Carma Bylund is a behavioral scientist with international expertise in healthcare communication across the cancer continuum and in dementia. Carma's research focuses on the development, implementation and testing of communication interventions for clinicians, patients and caregivers to improve health outcomes.
Areas of Expertise (8)
Doctor-Patient Communication on Telemedicine
Communication Skills Training for Residents and Fellows
Cancer Caregiving
Healthcare Communication
Doctor-Patient Communication
Doctor-Patient Communication About Online Health Information and Misinformation
Empathetic Communication in Clinical Settings
Clinical Communication About Cancer Clinical Trials
Articles (4)
Clinician approaches to communicating a dementia diagnosis: An interview study
PLOS OneEaston N. Wollney, et. al
2022-04-14
Individuals with cognitive impairment and their families place a high value on receiving a dementia diagnosis, but clinician approaches vary. There is a need for research investigating experiences of giving and receiving dementia diagnoses. The current study aimed to investigate clinician approaches to giving dementia diagnoses as part of a larger study investigating patient, caregiver and clinician experiences during the diagnosis encounter.
Clinicians’ Attitudes and Behaviors Towards Communicating Electronically with Patients: A Grounded Practical Theory Approach
Journal of Health CommunicationJordan M. Alpert, et. al
2022-04-05
Secure messaging (SM), asynchronous communication between patients and clinicians, is an increasingly popular tool among patients to contact clinicians about their care. Despite patients’ enthusiasm, clinicians have been hesitant to embrace the technology to communicate with patients. Using the theoretical and methodological framework of Grounded Practical Theory (GPT), we analyzed and interpreted clinicians’ perceptions, attitudes and approaches toward SM to communicate with patients.
Clinicians’ Perceptions of the Benefits and Challenges of Teleoncology as Experienced Through the COVID-19 Pandemic: Qualitative Study
JMIR CancerJordan M. Alpert, et. al
2022-02-24
COVID-19 thrust both patients and clinicians to use telemedicine in place of traditional in-person visits. Prepandemic, limited research had examined clinician-patient communication in telemedicine visits. The shift to telemedicine in oncology, or teleoncology, has placed attention on how the technology can be utilized to provide care for patients with cancer.Our objective was to describe oncology clinicians’ experiences with teleoncology and to uncover its benefits and challenges during the first 10 months of the COVID-19 pandemic.
Disparities in Patient-Centered Communication via Telemedicine
Telemedicine and e-HealthSamantha R. Paige, et. al
2022-02-08
This study investigated disparities in the uptake of telemedicine and the degree of patient-centeredness of telemedicine consultations among vulnerable patient populations. The focus includes rural adults and adults living with psychological distress and a high risk for chronic obstructive pulmonary disease (COPD). In August 2020, a random sample of 932 U.S. adults ≥35 years old with a history of smoking tobacco completed an online survey.
Social